Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2450 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 48.76 USD | +1.60% | +3.81% | +4.08% | +61.83% | 910.83 M USD | ||
| 2466 |  ALMS Alumis Inc. - Common Stock | 6.98 USD | +3.10% | -3.19% | -33.21% | +54.77% | 903.46 M USD | ||
| 2473 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.15 USD | +2.76% | +2.76% | -27.17% | +40.80% | 899.90 M USD | ||
| 2484 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.33 USD | +1.57% | -8.26% | -27.66% | -8.58% | 881.29 M USD | ||
| 2488 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.58 USD | -1.76% | -7.76% | -28.99% | +10.67% | 900.43 M USD | ||
| 2502 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.22 USD | -1.83% | -6.50% | -25.73% | +46.00% | 859.72 M USD | ||
| 2519 |  SANA Sana Biotechnology, Inc. - Common Stock | 2.80 USD | +2.94% | -3.11% | -20.23% | -38.19% | 838.21 M USD | ||
| 2520 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.17 USD | -2.80% | -8.55% | -19.19% | +0.48% | 825.03 M USD | ||
| 2532 |  ARDX Ardelyx, Inc. - Common Stock | 3.27 USD | +0.31% | -3.25% | -12.33% | -35.25% | 814.84 M USD | ||
| 2539 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 16.73 USD | -0.95% | -42.17% | -44.27% | -19.80% | 824.92 M USD | ||
| 2567 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.76 USD | -3.98% | -3.43% | -5.72% | -18.16% | 753.81 M USD | ||
| 2569 |  GERN Geron Corporation - Common Stock | 1.22 USD | +1.67% | +0.83% | -18.67% | -12.23% | 783.82 M USD | ||
| 2571 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.75 USD | -0.57% | -3.85% | -20.81% | +20.69% | 778.67 M USD | ||
| 2581 |  ANNX Annexon, Inc. - common stock | 3.99 USD | -0.50% | -3.16% | -13.26% | +26.67% | 756.42 M USD | ||
| 2591 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.18 USD | -0.83% | -4.65% | -8.18% | +108.12% | 738.84 M USD | ||
| 2594 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.66 USD | -1.63% | -4.92% | -22.84% | +47.48% | 739.17 M USD | ||
| 2599 |  SLDB Solid Biosciences Inc. - Common Stock | 6.82 USD | -0.44% | -2.29% | -30.19% | +19.65% | 731.28 M USD | ||
| 2607 |  VSTM Verastem, Inc. - Common Stock | 8.12 USD | -1.81% | +2.78% | +1.12% | -8.76% | 735.38 M USD | ||
| 2613 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.36 USD | -0.87% | -11.87% | +66.08% | +27.93% | 730.91 M USD | ||
| 2617 |  DSGN Design Therapeutics, Inc. - Common Stock | 11.48 USD | -1.80% | -6.21% | -24.07% | +64.71% | 718.44 M USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |